HENDERSON JOHN T bought CYTK
July 15, 2026 · Form 4 insider transaction
HENDERSON JOHN T bought 272 shares of Cytokinetics, Incorporated at $82.62 per share, a transaction worth $22.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
272
Price
$82.62
Total value
$22.5K
InsiderHENDERSON JOHN T
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 16, 2026
Shares owned after78,360
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant.